3 completed, 2 unknown, 1 not yet recruiting. 6 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Unknown 2, Not yet recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Liver Dysfunction: new trials by email Literature Review of Liver Dysfunction trials Research Report on Liver Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers NMP viability testing - Organ Transplantation, Liver Dysfunction | Phase 2 | Not yet recruiting | Rennes University Hospital | 99 | 2025-12-15 | 2025-08-15 |
| Cisplatin Combined with Oral TS-1 in Patients with Advanced Solid Tumors with Different Degrees of Liver Dysfunction TS-1 combined with cisplatin - Cancer, Liver Dysfunction | Phase 2 | Unknown | National University Hospital, Singapore | 48 | 2016-07-22 | 2024-09-19 |
| The Effects of Dexamethasone Administration on Jaundice Following Liver Resection Dexamethasone - Liver Dysfunction, Hepatectomy | Phase 2 / Phase 3 | Completed | Shanghai Zhongshan Hospital | 76 | 2016-06-01 | 2021-06-10 |
| Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver Cirrhosis Mivacurium Chloride - Liver Dysfunction | Phase 2 | Unknown | Tang-Du Hospital | 80 | 2014-10-01 | 2015-08-21 |
| The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease H.pylori eradication (Omeprazole, Amoxicillin, Bismuth subcitrate, Azithromycin) - Fatty Liver, Liver Dysfunction | Phase 2 | Completed | Tehran University of Medical Sciences | 100 | 2012-07-01 | 2013-07-08 |
| Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant Rejection Thymoglobulin, Corticosteroid, Tacrolimus - Liver Dysfunction, Rejection, Transplant | Phase 2 | Completed | Genzyme, a Sanofi Company | 75 | 2005-04-01 | 2015-03-18 |
Liver Diseases (6) · Digestive System Diseases (1) · Fatty Liver (1) · Hyperbilirubinemia (1) · Insulin Resistance (1) · Jaundice (1) · Neoplasms (1) · Rejection, Psychology (1) · Renal Insufficiency (1)
Digestive System Diseases (5) · Behavior (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Skin Manifestations (1) · Social Behavior (1)
Adrenal Cortex Hormones (1) · Amoxicillin (1) · Antilymphocyte Serum (1) · Azithromycin (1) · Cisplatin (1) · Dexamethasone (1) · Mivacurium (1) · Mycophenolic Acid (1) · Omeprazole (1) · Tacrolimus (1) · bismuth tripotassium dicitrate (1) · dexamethasone 21-phosphate (1) · thymoglobulin (1)
Genzyme, a Sanofi Company (1) · National University Hospital, Singapore (1) · Rennes University Hospital (1) · Shanghai Zhongshan Hospital (1) · Tang-Du Hospital (1) · Tehran University of Medical Sciences (1)
China (2) · Canada (1) · France (1) · Iran (1) · Singapore (1) · United States (1)
Hui-Chuan Sun, MD (1) · Raika Jamali, M.D. (1)
PMID 11231856, PMID 20940288, PMID 24224656, PMID 26176387
2016 (1)